• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CASI Pharmaceuticals, Inc. - Ordinary Shares (NQ:CASI)

    0.9650 -0.0250 (-2.53%)
    Streaming Delayed Price Updated: 10:54 AM EST, Dec 2, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,575
    Open 0.9700
    Bid (Size) 0.9500 (2,000)
    Ask (Size) 1.010 (100)
    Prev. Close 0.9900
    Today's Range 0.9500 - 0.9889
    52wk Range 0.9360 - 4.050
    Shares Outstanding 13,378,175
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    CASI Pharmaceuticals Announces Changes in Board Governance
    Via ACCESS Newswire
    News headline image
    CASI Pharmaceuticals Announces Third Quarter 2025 Business and Financial Results
    Via ACCESS Newswire

    Performance

    YTD
    -67.6%
    -67.6%
    1 Month
    -30.6%
    -30.6%
    3 Month
    -58.0%
    -58.0%
    6 Month
    -47.8%
    -47.8%
    1 Year
    -75.6%
    -75.6%

    More News

    Read More
    News headline image
    CASI Pharmaceuticals Receives and Appeals Delisting Determination from NASDAQ
    Via ACCESS Newswire
    News headline image
    CASI Pharmaceuticals to Participate at Guggenheim Healthcare Innovation Conference
    Via ACCESS Newswire
    News headline image
    CASI Pharmaceuticals Announces Upcoming Presentation of Clinical Results for CID-103 at the 67th American Society of Hematology (ASH) Annual Meeting
    Via ACCESS Newswire
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    CASI Pharmaceuticals Appoints James Huang to Board of Directors
    Via ACCESS Newswire
    News headline image
    CASI Pharmaceuticals Announces Safety Monitoring Committee Recommendation to Escalate CID-103 Dose to Next Cohort in Phase 1 Immune Thrombocytopenia (ITP) Study
    Via ACCESS Newswire
    News headline image
    CASI Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference
    Via ACCESS Newswire
    News headline image
    CASI Pharmaceuticals Appoints Barbara Krebs-Pohl, PhD to Board of Directors
    Via ACCESS Newswire
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
    Via Benzinga
    News headline image
    CASI Pharmaceuticals Announces Second Quarter 2025 Business and Financial Results
    Via ACCESS Newswire
    News headline image
    CASI Pharmaceuticals to Participate at Cantor Global Healthcare Conference 2025
    Via ACCESS Newswire
    News headline image
    These stocks are moving in today's pre-market session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Dayforce Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
    Via Benzinga
    News headline image
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    Top movers in Friday's session ↗
    Via Chartmill
    News headline image
    What's going on in today's session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
    Via Benzinga
    News headline image
    Loop Industries (NASDAQ: LOOP) Ignites Paradigm Shift – Twist™ A Breakthrough in Circular Sustainability – More Stocks Inside
    Via AB Newswire
    Topics Economy
    News headline image
    Top stock movements in today's session. ↗
    Via Chartmill
    News headline image
    CASI Pharmaceuticals Announces FDA Clearance of IND Application for CID-103 in Renal Allograft Antibody-Mediated Rejection (AMR)
    Via ACCESS Newswire

    Frequently Asked Questions

    Is CASI Pharmaceuticals, Inc. - Ordinary Shares publicly traded?
    Yes, CASI Pharmaceuticals, Inc. - Ordinary Shares is publicly traded.
    What exchange does CASI Pharmaceuticals, Inc. - Ordinary Shares trade on?
    CASI Pharmaceuticals, Inc. - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for CASI Pharmaceuticals, Inc. - Ordinary Shares?
    The ticker symbol for CASI Pharmaceuticals, Inc. - Ordinary Shares is CASI on the Nasdaq Stock Market
    What is the current price of CASI Pharmaceuticals, Inc. - Ordinary Shares?
    The current price of CASI Pharmaceuticals, Inc. - Ordinary Shares is 0.9650
    When was CASI Pharmaceuticals, Inc. - Ordinary Shares last traded?
    The last trade of CASI Pharmaceuticals, Inc. - Ordinary Shares was at 12/02/25 10:54 AM ET
    What is the market capitalization of CASI Pharmaceuticals, Inc. - Ordinary Shares?
    The market capitalization of CASI Pharmaceuticals, Inc. - Ordinary Shares is 12.91M
    How many shares of CASI Pharmaceuticals, Inc. - Ordinary Shares are outstanding?
    CASI Pharmaceuticals, Inc. - Ordinary Shares has 13M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.